T1	B-Protein	0	2	IL	IL	B-NP	NN	B-protein	5	NMOD	B-protein
T1	I-Protein	2	3	-	-	I-NP	HYPH	I-protein	1	NMOD	I-protein
T1	I-Protein	3	4	2	2	I-NP	CD	I-protein	1	NMOD	I-protein
O	O	5	9	gene	gene	I-NP	NN	O	5	NMOD	O
O	O	10	20	expression	expression	I-NP	NN	O	11	NMOD	O
O	O	21	24	and	and	O	CC	O	11	NMOD	O
T13	B-Entity	25	27	NF	NF	B-NP	NN	B-protein	10	NMOD	B-protein
T13	I-Entity	27	28	-	-	B-NP	HYPH	I-protein	10	NMOD	I-protein
T13	I-Entity	28	33	kappa	kappa	I-NP	NN	I-protein	10	NMOD	I-protein
T13	I-Entity	34	35	B	B	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	36	46	activation	activation	I-NP	NN	O	14	SUB	O
O	O	47	54	through	through	B-PP	IN	O	11	NMOD	O
T2	B-Protein	55	59	CD28	CD28	B-NP	NN	B-protein	12	PMOD	B-protein
O	O	60	68	requires	require	B-VP	VBZ	O	0	ROOT	O
O	O	69	77	reactive	reactive	B-NP	JJ	O	17	NMOD	O
O	O	78	84	oxygen	oxygen	I-NP	NN	O	17	NMOD	O
O	O	85	95	production	production	I-NP	NN	O	14	OBJ	O
O	O	96	98	by	by	B-PP	IN	O	14	VMOD	O
O	O	99	100	5	5	B-NP	CD	O	21	NMOD	O
O	O	100	101	-	-	I-NP	HYPH	O	21	NMOD	O
O	O	101	113	lipoxygenase	lipoxygenase	I-NP	NN	B-protein	18	PMOD	B-protein
O	O	113	114	.	.	O	.	O	14	P	O

O	O	116	126	Activation	Activation	B-NP	NN	O	7	SUB	O
O	O	127	129	of	of	B-PP	IN	O	1	NMOD	O
O	O	130	133	the	the	B-NP	DT	O	6	NMOD	O
T3	B-Protein	134	138	CD28	CD28	I-NP	NN	B-protein	6	NMOD	B-protein
O	O	139	146	surface	surface	I-NP	NN	I-protein	6	NMOD	I-protein
O	O	147	155	receptor	receptor	I-NP	NN	I-protein	2	PMOD	I-protein
O	O	156	164	provides	provide	B-VP	VBZ	O	0	ROOT	O
O	O	165	166	a	a	B-NP	DT	O	11	NMOD	O
O	O	167	172	major	major	I-NP	JJ	O	11	NMOD	O
O	O	173	186	costimulatory	costimulatory	I-NP	JJ	O	11	NMOD	O
O	O	187	193	signal	signal	I-NP	NN	O	7	OBJ	O
O	O	194	197	for	for	B-PP	IN	O	11	NMOD	O
O	O	198	199	T	T	B-NP	NN	O	15	NMOD	O
O	O	200	204	cell	cell	I-NP	NN	O	15	NMOD	O
O	O	205	215	activation	activation	I-NP	NN	O	12	PMOD	O
O	O	216	225	resulting	result	B-VP	VBG	O	11	NMOD	O
O	O	226	228	in	in	B-PP	IN	O	16	VMOD	O
O	O	229	237	enhanced	enhance	B-NP	VBN	O	19	NMOD	O
O	O	238	248	production	production	I-NP	NN	O	17	PMOD	O
O	O	249	251	of	of	B-PP	IN	O	19	NMOD	O
T4	B-Protein	252	263	interleukin	interleukin	B-NP	NN	B-protein	31	NMOD	B-protein
T4	I-Protein	263	264	-	-	B-NP	HYPH	O	21	P	O
T4	I-Protein	264	265	2	2	I-NP	CD	O	21	NMOD	O
O	O	266	267	(	(	O	(	O	28	DEP	O
T5	B-Protein	267	269	IL	IL	B-NP	NN	B-protein	27	NMOD	B-protein
T5	I-Protein	269	270	-	-	O	HYPH	I-protein	27	P	I-protein
T5	I-Protein	270	271	2	2	B-NP	CD	I-protein	28	DEP	I-protein
O	O	271	272	)	)	O	)	O	21	NMOD	O
O	O	273	276	and	and	O	CC	O	31	NMOD	O
O	O	277	281	cell	cell	B-NP	NN	O	31	NMOD	O
O	O	282	295	proliferation	proliferation	I-NP	NN	O	20	PMOD	O
O	O	295	296	.	.	O	.	O	7	P	O

O	O	297	299	In	In	B-PP	IN	O	6	VMOD	O
O	O	300	307	primary	primary	B-NP	JJ	B-cell_type	4	NMOD	B-cell_type
O	O	308	309	T	T	I-NP	NN	I-cell_type	4	NMOD	I-cell_type
O	O	310	321	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	1	PMOD	I-cell_type
O	O	322	324	we	we	B-NP	PRP	O	6	SUB	O
O	O	325	329	show	show	B-VP	VBP	O	0	ROOT	O
O	O	330	334	that	that	B-SBAR	IN	O	6	VMOD	O
T6	B-Protein	335	339	CD28	CD28	B-NP	NN	B-protein	9	NMOD	B-protein
O	O	340	348	ligation	ligation	I-NP	NN	O	10	SUB	O
O	O	349	354	leads	lead	B-VP	VBZ	O	7	SBAR	O
O	O	355	357	to	to	B-PP	TO	O	10	VMOD	O
O	O	358	361	the	the	B-NP	DT	O	15	NMOD	O
O	O	362	367	rapid	rapid	I-NP	JJ	O	15	NMOD	O
O	O	368	381	intracellular	intracellular	I-NP	JJ	O	15	NMOD	O
O	O	382	391	formation	formation	I-NP	NN	O	11	PMOD	O
O	O	392	394	of	of	B-PP	IN	O	15	NMOD	O
O	O	395	403	reactive	reactive	B-NP	JJ	O	19	NMOD	O
O	O	404	410	oxygen	oxygen	I-NP	NN	O	19	NMOD	O
O	O	411	424	intermediates	intermediate	I-NP	NNS	O	16	PMOD	O
O	O	425	426	(	(	O	(	O	22	DEP	O
O	O	426	430	ROIs	ROI	B-NP	NNS	O	22	DEP	O
O	O	430	431	)	)	O	)	O	19	NMOD	O
O	O	432	437	which	which	B-NP	WDT	O	19	NMOD	O
O	O	438	441	are	be	B-VP	VBP	O	23	SBAR	O
O	O	442	450	required	require	I-VP	VBN	O	24	VC	O
O	O	451	454	for	for	B-PP	IN	O	25	VMOD	O
T7	B-Protein	455	459	CD28	CD28	B-NP	NN	B-protein	30	NMOD	B-protein
O	O	459	460	-	-	O	HYPH	O	30	NMOD	O
O	O	460	468	mediated	mediate	B-NP	VBN	O	30	NMOD	O
O	O	469	479	activation	activation	I-NP	NN	O	26	PMOD	O
O	O	480	482	of	of	B-PP	IN	O	30	NMOD	O
O	O	483	486	the	the	B-NP	DT	O	36	NMOD	O
T14	B-Entity	487	489	NF	NF	I-NP	NN	B-protein	36	NMOD	B-protein
T14	I-Entity	489	490	-	-	B-NP	HYPH	I-protein	36	NMOD	I-protein
T14	I-Entity	490	495	kappa	kappa	I-NP	NN	I-protein	36	NMOD	I-protein
T14	I-Entity	496	497	B	B	I-NP	NN	I-protein	41	NMOD	I-protein
T14	I-Entity	497	498	/	/	B-NP	SYM	O	41	NMOD	O
T8,T14,T15	B-Protein,I-Entity,B-Entity	498	502	CD28	CD28	I-NP	NN	B-protein	41	NMOD	B-protein
T14,T15	I-Entity,I-Entity	502	503	-	-	B-NP	HYPH	O	41	NMOD	O
T14,T15	I-Entity,I-Entity	503	513	responsive	responsive	I-NP	JJ	O	41	NMOD	O
T14,T15	I-Entity,I-Entity	514	521	complex	complex	I-NP	NN	O	46	NMOD	O
O	O	522	525	and	and	I-NP	CC	O	46	NMOD	O
T9	B-Protein	526	528	IL	IL	I-NP	NN	B-protein	46	NMOD	B-protein
T9	I-Protein	528	529	-	-	O	HYPH	I-protein	46	NMOD	I-protein
T9	I-Protein	529	530	2	2	B-NP	CD	I-protein	46	NMOD	I-protein
O	O	531	541	expression	expression	I-NP	NN	O	31	PMOD	O
O	O	541	542	.	.	O	.	O	6	P	O

O	O	543	554	Delineation	Delineation	B-NP	NN	O	7	SUB	O
O	O	555	557	of	of	B-PP	IN	O	1	NMOD	O
O	O	558	561	the	the	B-NP	DT	O	6	NMOD	O
T10	B-Protein	562	566	CD28	CD28	I-NP	NN	B-protein	6	NMOD	B-protein
O	O	567	576	signaling	signaling	I-NP	NN	O	6	NMOD	O
O	O	577	584	cascade	cascade	I-NP	NN	O	2	PMOD	O
O	O	585	588	was	be	B-VP	VBD	O	0	ROOT	O
O	O	589	594	found	find	I-VP	VBN	O	7	VC	O
O	O	595	597	to	to	I-VP	TO	O	10	VMOD	O
O	O	598	605	involve	involve	I-VP	VB	O	8	VMOD	O
O	O	606	613	protein	protein	B-NP	NN	B-protein	14	NMOD	B-protein
O	O	614	622	tyrosine	tyrosine	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	623	629	kinase	kinase	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	630	638	activity	activity	I-NP	NN	O	10	OBJ	O
O	O	638	639	,	,	O	,	O	10	P	O
O	O	640	648	followed	follow	B-VP	VBN	O	10	VMOD	O
O	O	649	651	by	by	B-PP	IN	O	16	VMOD	O
O	O	652	655	the	the	B-NP	DT	O	19	NMOD	O
O	O	656	666	activation	activation	I-NP	NN	O	26	NMOD	O
O	O	667	669	of	of	B-PP	IN	O	19	NMOD	O
O	O	670	683	phospholipase	phospholipase	B-NP	NN	B-protein	22	NMOD	B-protein
O	O	684	686	A2	A2	I-NP	NN	I-protein	20	PMOD	I-protein
O	O	687	690	and	and	O	CC	O	26	NMOD	O
O	O	691	692	5	5	B-NP	CD	O	26	NMOD	O
O	O	692	693	-	-	I-NP	HYPH	O	26	NMOD	O
O	O	693	705	lipoxygenase	lipoxygenase	I-NP	NN	B-protein	17	PMOD	B-protein
O	O	705	706	.	.	O	.	O	7	P	O

O	O	707	710	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	711	715	data	datum	I-NP	NNS	O	3	SUB	O
O	O	716	723	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	724	728	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	729	741	lipoxygenase	lipoxygenase	B-NP	NN	B-protein	6	NMOD	B-protein
O	O	742	753	metabolites	metabolite	I-NP	NNS	I-protein	7	SUB	I-protein
O	O	754	762	activate	activate	B-VP	VBP	O	4	SBAR	O
O	O	763	766	ROI	ROI	B-NP	NN	O	9	NMOD	O
O	O	767	776	formation	formation	I-NP	NN	O	7	OBJ	O
O	O	777	782	which	which	B-NP	WDT	O	9	NMOD	O
O	O	783	787	then	then	B-ADVP	RB	O	12	VMOD	O
O	O	788	794	induce	induce	B-VP	VBP	O	10	SBAR	O
T11	B-Protein	795	797	IL	IL	B-NP	NN	B-protein	16	NMOD	B-protein
T11	I-Protein	797	798	-	-	O	HYPH	I-protein	16	NMOD	I-protein
T11	I-Protein	798	799	2	2	B-NP	CD	I-protein	16	NMOD	I-protein
O	O	800	810	expression	expression	I-NP	NN	O	12	OBJ	O
O	O	811	814	via	via	B-PP	IN	O	12	VMOD	O
T16	B-Entity	815	817	NF	NF	B-NP	NN	B-protein	22	NMOD	B-protein
T16	I-Entity	817	818	-	-	B-NP	HYPH	I-protein	22	NMOD	I-protein
T16	I-Entity	818	823	kappa	kappa	I-NP	NN	I-protein	22	NMOD	I-protein
T16	I-Entity	824	825	B	B	I-NP	NN	I-protein	22	NMOD	I-protein
O	O	826	836	activation	activation	I-NP	NN	O	17	PMOD	O
O	O	836	837	.	.	O	.	O	3	P	O

O	O	838	843	These	These	B-NP	DT	O	2	NMOD	O
O	O	844	852	findings	finding	I-NP	NNS	O	3	SUB	O
O	O	853	859	should	should	B-VP	MD	O	0	ROOT	O
O	O	860	862	be	be	I-VP	VB	O	3	VC	O
O	O	863	869	useful	useful	B-ADJP	JJ	O	4	PRD	O
O	O	870	873	for	for	B-PP	IN	O	5	AMOD	O
O	O	874	885	therapeutic	therapeutic	B-NP	JJ	O	8	NMOD	O
O	O	886	896	strategies	strategy	I-NP	NNS	O	11	NMOD	O
O	O	897	900	and	and	O	CC	O	11	NMOD	O
O	O	901	904	the	the	B-NP	DT	O	11	NMOD	O
O	O	905	916	development	development	I-NP	NN	O	6	PMOD	O
O	O	917	919	of	of	B-PP	IN	O	11	NMOD	O
O	O	920	938	immunosuppressants	immunosuppressant	B-NP	NNS	O	12	PMOD	O
O	O	939	948	targeting	target	B-VP	VBG	O	13	NMOD	O
O	O	949	952	the	the	B-NP	DT	O	18	NMOD	O
T12	B-Protein	953	957	CD28	CD28	I-NP	NN	B-protein	18	NMOD	B-protein
O	O	958	971	costimulatory	costimulatory	I-NP	JJ	O	18	NMOD	O
O	O	972	979	pathway	pathway	I-NP	NN	O	14	OBJ	O
O	O	979	980	.	.	O	.	O	3	P	O
